Toulouse, Midi-Pyrenees, France In 2008 was created WiSEED, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Toulouse. The company was established in Europe in France.
Among the most popular fund investment industries, there are Life Science, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Intuiface, Vectalys, Nau00efo Technologies. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the WiSEED, startups are often financed by SOSV, RebelBio, FaDiu00e8se. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Cu00e9dric Delorme, Galia Gestion. In the next rounds fund is usually obtained by Bpifrance, Wellcome Trust, SOSV.
The fund was created by Nicolas Su00c9Ru00c8S, Thierry MERQUIOL.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 1 - 5 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2018. Opposing the other organizations, this WiSEED works on 24 percentage points less the average amount of lead investments.
Related Funds
| Fund Name | Location |
| Acorn Capital | Australia, Melbourne, Victoria |
| Atresmedia | Community of Madrid, Madrid, Spain |
| Avic Avionics | Beijing, Beijing, China |
| Beta Bayview | - |
| Business Incubators and Accelerators Company(BIAC Incubators) | Ar Riyad, Riyadh, Saudi Arabia |
| CIBC | Canada, Ontario, Toronto |
| Delta Investment | - |
| Ericsson-Deutsche Technology Fund | Australia, New South Wales, Sydney |
| Glenview Capital Management | New York, New York, United States |
| Heights Capital Management | California, San Francisco, United States |
| ITIC: Industrial Technology Investment Corporation | Taipei, Taiwan |
| Kirlan Venture Capital | Seattle, United States, Washington |
| Lam Research | California, Fremont, United States |
| Magenta Venture Partners | Herzliya, Israel, Tel Aviv |
| Marshmallow | Japan, Tokyo |
| Maywic Select Investments | Cincinnati, Ohio, United States |
| No 8 Ventures | - |
| PLS Venture Capital Partners | France, Lyon, Rhone-Alpes |
| Ririshun Lejia Home Furnishing Trade | China, Qingdao Shi, Shandong |
| TASC Ventures | Madison, United States, Wisconsin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Leasi | $1M | 01 Jul 2024 | Trondheim, Sor-Trondelag, Norway | ||
BiPER Therapeutics | $354K | 14 Feb 2023 | Strasbourg, Alsace, France | ||
Dianosic | $5M | 06 Feb 2023 | Strasbourg, Grand Est, France | ||
BioIntrant | $1M | 20 Jan 2022 | Pertuis, Provence-Alpes-Cote d'Azur, France | ||
SPARTHA Medical | $1M | 08 Dec 2021 | Strasbourg, Alsace, France | ||
WATTPARK | $1M | 15 Nov 2021 | Centre, Ile-de-France, France | ||
| $1M | 04 Jan 2020 | France, Auvergne-Rhône-Alpes | |||
Lattice Medical | $2M | 05 Nov 2018 | France, Hauts-de-France, France | ||
Levels3D | $1M | 22 May 2018 | Troyes, Grand Est |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Leasi | $1M | 01 Jul 2024 | Trondheim, Sor-Trondelag, Norway | ||
BiPER Therapeutics | $354K | 14 Feb 2023 | Strasbourg, Alsace, France | ||
Dianosic | $5M | 06 Feb 2023 | Strasbourg, Grand Est, France | ||
BioIntrant | $1M | 20 Jan 2022 | Pertuis, Provence-Alpes-Cote d'Azur, France | ||
SPARTHA Medical | $1M | 08 Dec 2021 | Strasbourg, Alsace, France | ||
WATTPARK | $1M | 15 Nov 2021 | Centre, Ile-de-France, France | ||
| $1M | 04 Jan 2020 | France, Auvergne-Rhône-Alpes | |||
Lattice Medical | $2M | 05 Nov 2018 | France, Hauts-de-France, France | ||
Levels3D | $1M | 22 May 2018 | Troyes, Grand Est |
